Breast Neoplasms: all 12,828 studies

Page 56 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.

• WeCanManage. An mHealth Self-management ToolCompletedNCT06185738Not applicable
• Choices About Genetic Testing And Learning Your Risk With Smart TechnologyCompletedNCT06184867Not applicable
• Effect of Aromatase Inhibitors on Ultrasonographic Measurements and Static and Dynamic Balance Scores in Breast CancerCompletedNCT06184074
• Awareness Based Stress Reduction Program Applied to Breast Cancer Patients Receiving ChemotherapyCompletedNCT06183164Not applicable
• CALM: Managing Distress in Malignant Brain CancerCompletedNCT06180460Not applicable
• Effect of Bra Use During Radiotherapy for Breast Cancer RadiotherapyCompletedNCT06178861Not applicable
• Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"Active, not recruitingNCT06176339Phase 2
• Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor DiagnosisCompletedNCT06172270
• PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast CancerActive, not recruitingNCT06172127Phase 2
• Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
• A Multicenter and Real-world Analysis of RC48-ADC in Patients With HER2-positive or HER2-low Expressing, Locally Advanced or Metastatic Breast CancerCompletedNCT06168227
• Using Color Doppler US Artifact to Identify Tumor MarkersActive, not recruitingNCT06166173
• Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast CancerTerminatedNCT06161792Phase 2
• Enhancing Therapy Adherence Among Metastatic Breast Cancer PatientsCompletedNCT06161181Not applicable
• Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast CancerCompletedNCT06158347Not applicable
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsActive, not recruitingNCT06157892Phase 2
• Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast CancerStatus unknownNCT06156761Not applicable
• The Effect of Technological Based Rehabilitation Practices After Breast Cancer SurgeryCompletedNCT06156397Not applicable
• Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer PatientsCompletedNCT06155331Phase 2
• Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast CancerStatus unknownNCT06152471Phase 3
• Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast CancerCompletedNCT06151639
• Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast CancerCompletedNCT06149377
• A Study of 1 8F-FDHT PET/MRIScans in Women With Breast CancerWithdrawnNCT06145399Early Phase 1
• Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast CancerActive, not recruitingNCT06144944Phase 3
• Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast CancerStatus unknownNCT06143553Phase 3
• Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant ReconstructionCompletedNCT06143020Not applicable
• Comparative Analysis of Two Animal-derived ADMs in Irradiated Implant-based ReconstructionCompletedNCT06139588
• Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant ChemotherapyCompletedNCT06137833Not applicable
• Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal MetastasisWithdrawnNCT06137651Phase 1
• An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung CancerCompletedNCT06136923Not applicable
• Clinical Outcomes of Patients Undergoing Skin-Reducing MastectomiesCompletedNCT06133452
• Patient Reported Outcomes Using Mepitel Film During RadiotherapyCompletedNCT06133218Not applicable
• NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer PatientsCompletedNCT06131424
• Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast CancerActive, not recruitingNCT06130826Phase 1
• Spatial Location of Breast Cancer Local Recurrence After MastectomyActive, not recruitingNCT06130111
• Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.TerminatedNCT06126003
• TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)TerminatedNCT06125522Phase 1/2
• The Effect of Melatonin Supplementation on Fatigue Symptoms During Chemotherapy Treatment of Breast Cancer PatientsCompletedNCT06125353Not applicable
• HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation CouncilCompletedNCT06125314
• Geriatric Assessment and Promotores (GAP) Pilot Feasibility StudyCompletedNCT06125145Not applicable
• Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through TreatmentCompletedNCT06121258Not applicable
• Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node BiopsyCompletedNCT06120439Not applicable
• Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and RadiotherapyCompletedNCT06119633Not applicable
• A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast CancerCompletedNCT06115902Phase 1
• Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa CountyCompletedNCT06112795
• Mobile Health for Adherence in Breast Cancer PatientsActive, not recruitingNCT06112613Not applicable
• A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerActive, not recruitingNCT06112379Phase 3
• The Effect of Mindfulness-based Yoga and Meditation on Some Parameters in Breast Cancer PatientsCompletedNCT06110832Not applicable
• A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast CancerActive, not recruitingNCT06110793Phase 1/2
• Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast CancerCompletedNCT06107790Phase 3
• Improving Muslim Women's Uptake of Cancer Screening (IMCAN)CompletedNCT06106165Not applicable
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentActive, not recruitingNCT06105632Phase 2
• Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast CancerWithdrawnNCT06105008Phase 2
• Prospective Ultrafast MRI Radiomics for Breast CancerCompletedNCT06104189
• Survival of BCS vs Mx in Asymptomatic Screen-detected NPBCCompletedNCT06103032
• Chronic Cancer Pain Management ProgramCompletedNCT06101849Not applicable
• A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)Active, not recruitingNCT06100874Phase 2
• HOBBIT 3: Mental Exercises and Temporal AlterationCompletedNCT06100068Not applicable
• Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast CancerCompletedNCT06098599Phase 1
• The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer TreatmentCompletedNCT06096623
• Prospective Radiomics Study for Breast CancerCompletedNCT06095414
• The Effect of Inspiratory Muscle Training on Breast Cancer Patients Undergoing SurgeryCompletedNCT06091696Not applicable
• MR Correlated Spectroscopic Imaging for Diagnosing Breast CancerCompletedNCT06090630Early Phase 1
• The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer SurgeryCompletedNCT06087237Phase 2
• Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating AlpelisibCompletedNCT06083038
• Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and FunctionCompletedNCT06081127Not applicable
• Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program OutcomesCompletedNCT06078761
• Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot StudyCompletedNCT06076616Not applicable
• A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast CancerCompletedNCT06075758
• Effect of Aerobic Exercises on Trace Elements in Post-menopausal Women After RadiotherapyCompletedNCT06070155Not applicable
• Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-BlockadeActive, not recruitingNCT06068985Phase 2
• Tumor-Derived FGF19CompletedNCT06068257
• "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast CancerTerminatedNCT06067061Phase 1/2
• Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related LymphedemaCompletedNCT06065423Not applicable
• Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsTerminatedNCT06065059Phase 1/2
• Contrast-Enhanced Stereotactic BiopsyCompletedNCT06062992
• Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide PolymorphismsActive, not recruitingNCT06062810Phase 2/3
• Digital Tool Enhancing GPs' Information Management for Patients with Multimorbidity - a Pilot StudyCompletedNCT06061172Not applicable
• Personalized Breast Cancer ScreeningActive, not recruitingNCT06060938Not applicable
• Genetic Testing to Improve Management of Patients Undergoing Breast BiopsySuspendedNCT06060561
• Exercises Using Virtual Reality on Cancer PatientsCompletedNCT06058936Not applicable
• Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility StudyWithdrawnNCT06057636Not applicable
• A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast CancerActive, not recruitingNCT06057610Phase 3
• Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiologistsCompletedNCT06056843Not applicable
• Study of Anxiety After a Session of Energy Resonance by Cutaneous StimulationCompletedNCT06056414Not applicable
• Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic TherapyActive, not recruitingNCT06055881Not applicable
• Heart Health After Cancer Treatment (HEART-ACT)CompletedNCT06055803Not applicable
• Hand-Foot Exercises on Peripheral NeuropathyCompletedNCT06055088Not applicable
• Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)Active, not recruitingNCT06053775Not applicable
• Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle OutcomesWithdrawnNCT06052345
• The Effect of Simulation-Based Breast Health Education on Breast Cancer Awareness and Breast Self-Examination PracticesCompletedNCT06051331Not applicable
• Combining CEM and Magnetic Seed Localization of Non-Palpable Breast TumorsCompletedNCT06049446
• T-DXd Therapy for HER2-low Breast Cancer Patients With Brain MetastasesActive, not recruitingNCT06048718Phase 2
• Survival Monitoring in Russian Cancer RegistriesActive, not recruitingNCT06043947
• Early Detection of Breast CancerStatus unknownNCT06043661
• Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast CancerCompletedNCT06040593
• CARE: Cancer Risk Perception and Women of ColorCompletedNCT06036875
• Evaluation of the Medical Service by Socio-aesthetics in OncologyCompletedNCT06035731Not applicable
• Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study.Active, not recruitingNCT06026631Not applicable
• Pattern of Clinical Presentation of Different Breast Disease in Surgical Opd at BPKIHSCompletedNCT06026176

← Breast Neoplasms overview